DBV Technologies S.A. (NASDAQ:DBVT – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $3.91 and traded as high as $4.46. DBV Technologies shares last traded at $4.39, with a volume of 6,288 shares trading hands.
Analysts Set New Price Targets
Several research firms have weighed in on DBVT. HC Wainwright increased their target price on shares of DBV Technologies from $25.00 to $35.00 and gave the company a “buy” rating in a research report on Thursday, October 24th. StockNews.com assumed coverage on shares of DBV Technologies in a research note on Tuesday. They issued a “hold” rating for the company. Finally, JMP Securities restated a “market outperform” rating and set a $10.00 target price on shares of DBV Technologies in a research report on Friday, January 10th.
Read Our Latest Research Report on DBVT
DBV Technologies Trading Up 0.5 %
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in DBV Technologies stock. Boxer Capital Management LLC acquired a new stake in shares of DBV Technologies S.A. (NASDAQ:DBVT – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 50,000 shares of the company’s stock, valued at approximately $154,000. Boxer Capital Management LLC owned approximately 0.24% of DBV Technologies as of its most recent SEC filing. Institutional investors own 71.74% of the company’s stock.
About DBV Technologies
DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis.
See Also
- Five stocks we like better than DBV Technologies
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for DBV Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DBV Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
